Merrie Mosedale

3.2k citations

30 papers · 2.5k indexed · 1 hit paper · h-index 17

Co-authors: Deborah M. Muoio Timothy R. Koves James R. Bain John R. Ussher Olga Ilkayeva Robert C. Noland Christopher B. Newgard Dorothy H. Slentz
Topics: Drug-Induced Hepatotoxicity and Protection (13 papers)Drug Transport and Resistance Mechanisms (6 papers)Pharmacogenetics and Drug Metabolism (6 papers)
Cited by: Physiology Pharmacology Clinical Biochemistry
Journals: Journal of Biological Chemistry PLoS ONE Cell Metabolism
Partner nations: United States United Kingdom Saudi Arabia

In The Last Decade

Merrie Mosedale

29 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance

2008 1.6k citations Timothy R. Koves, John R. Ussher et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Merrie Mosedale

Since Specialization

Citations

This map shows the geographic impact of Merrie Mosedale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merrie Mosedale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrie Mosedale more than expected).

Fields of papers citing papers by Merrie Mosedale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merrie Mosedale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merrie Mosedale. The network helps show where Merrie Mosedale may publish in the future.

Co-authorship network of co-authors of Merrie Mosedale

This figure shows the co-authorship network connecting the top 25 collaborators of Merrie Mosedale. A scholar is included among the top collaborators of Merrie Mosedale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merrie Mosedale. Merrie Mosedale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities 2024 ·Toxicological Sciences ·(unknown),Xiaoli Meng,Jane Barber,Merrie Mosedale,Amy E. Chadwick,Paul B. Watkins,Dean J. Naisbitt	0
2	Activation of tolvaptan-responsive T-cell clones with the structurally-related mozavaptan 2022 ·Toxicology Letters ·(unknown),Xiaoli Meng,Merrie Mosedale,Dean J. Naisbitt	2
3	Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice 2021 ·Toxicology ·Merrie Mosedale,(unknown),J. Scott Eaddy,Patrick Kirby,Francis S. Wolenski,Yvonne P. Dragan,William Valdar	10
4	Fit-For-Purpose Hepatocyte Models Enable the Identification of Early Events Contributing to Idelalisib-Induced Liver Injury 2020 ·Manisha Nautiyal,Caroline Bauch,Paul Walker,Paul B. Watkins,Merrie Mosedale	1
5	Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury 2020 ·Toxicology in Vitro ·Manisha Nautiyal,(unknown),John K. Fallon,Kristina Wolf,Jingli Liu,Darlene Dixon,Philip C. Smith,Merrie Mosedale	9
6	Differential Detergent Fractionation of Membrane Protein From Small Samples of Hepatocytes and Liver Tissue for Quantitative Proteomic Analysis of Drug Metabolizing Enzymes and Transporters 2020 ·Journal of Pharmaceutical Sciences ·(unknown),John K. Fallon,Manisha Nautiyal,Merrie Mosedale,Philip C. Smith	10
7	Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression 2020 ·Journal of Pharmaceutical Sciences ·Raju Khatri,(unknown),(unknown),John K. Fallon,Craig Sykes,Amanda P. Schauer,Melina M. Malinen,Merrie Mosedale,Paul B. Watkins,Angela D. M. Kashuba,Kim Boggess,Philip C. Smith,Kim L. R. Brouwer,Craig R. Lee	19
8	Bioprinted liver provides early insight into the role of Kupffer cells in TGF-β1 and methotrexate-induced fibrogenesis 2019 ·PLoS ONE ·(unknown),Deborah G. Nguyen,David A. Gerber,Sharon C. Presnell,Merrie Mosedale,Paul B. Watkins	65
9	Mouse Population-Based Approaches to Investigate Adverse Drug Reactions 2018 ·Drug Metabolism and Disposition ·Merrie Mosedale	12
10	miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model 2017 ·Toxicological Sciences ·Merrie Mosedale,J. Scott Eaddy,O. Joseph Trask,(unknown),Kristina Wolf,Edward L. LeCluyse,Brenton R. Ware,Salman R. Khetani,Jingtao Lu,William J. Brock,Sharin E. Roth,Paul B. Watkins	40
11	Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa) 2017 ·Toxicological Sciences ·Merrie Mosedale,Donald Button,Jonathan P. Jackson,Kimberly Freeman,Kenneth R. Brouwer,Anthony O. Caggiano,Andrew Eisen,Jennifer F. Iaci,Tom J. Parry,(unknown),Maya Srinivas,Paul B. Watkins	14
12	Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors 2016 ·Toxicological Sciences ·Jeffrey L. Woodhead,William J. Brock,Sharin E. Roth,Susan E. Shoaf,Kim L. R. Brouwer,Rachel J. Church,Tom N. Grammatopoulos,Linsey Stiles,Scott Q. Siler,Brett A. Howell,Merrie Mosedale,Paul B. Watkins,Lisl K.M. Shoda	71
13	Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach 2016 ·Toxicological Sciences ·Merrie Mosedale,Yunjung Kim,William J. Brock,Sharin E. Roth,Tim Wiltshire,J. Scott Eaddy,Gregory R. Keele,Robert W. Corty,Yuying Xie,William Valdar,Paul B. Watkins	38
14	Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury? 2016 ·Toxicological Sciences ·(unknown),Merrie Mosedale,Kristina Wolf,Edward L. LeCluyse,Paul B. Watkins	57
15	A Systems Biology Approach Utilizing a Mouse Diversity Panel Identifies Genetic Differences Influencing Isoniazid-Induced Microvesicular Steatosis 2014 ·Toxicological Sciences ·Rachel J. Church,Hong Wu,Merrie Mosedale,Susan Sumner,Wimal Pathmasiri,C. Lisa Kurtz,Mathew T. Pletcher,J. Scott Eaddy,Karamjeet Pandher,Monica Singer,(unknown),Paul B. Watkins,Karissa Adkins,Alison H. Harrill	42
16	Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice 2014 ·Food and Chemical Toxicology ·Rachel J. Church,Daniel M. Gatti,Thomas Urban,Nanye Long,Xi Yang,Qiang Shi,J. Scott Eaddy,Merrie Mosedale,(unknown),Gary A. Churchill,Victor J. Navarro,Paul B. Watkins,David W. Threadgill,Alison H. Harrill	69
17	Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug 2014 ·Toxicology and Applied Pharmacology ·Merrie Mosedale,Hong Wu,C. Lisa Kurtz,Stephen P. Schmidt,Karissa Adkins,(unknown)	11
18	PPARγ coactivator-1α contributes to exercise-induced regulation of intramuscular lipid droplet programming in mice and humans 2012 ·Journal of Lipid Research ·Timothy R. Koves,Lauren M. Sparks,Jean‐Paul Kovalik,Merrie Mosedale,Ramamani Arumugam,Karen L. DeBalsi,(unknown),Leigh B. Thorne,Esther Phielix,Ruth C. R. Meex,C. Lawrence Kien,Matthijs K. C. Hesselink,Patrick Schrauwen,Deborah M. Muoio	82
19	Neurexin-1α Contributes to Insulin-containing Secretory Granule Docking 2012 ·Journal of Biological Chemistry ·Merrie Mosedale,(unknown),(unknown),Nai‐Wen Chi,Steven Chessler	28
20	Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistancebreakdown → 2008 ·Cell Metabolism ·Timothy R. Koves,John R. Ussher,Robert C. Noland,Dorothy H. Slentz,Merrie Mosedale,Olga Ilkayeva,James R. Bain,Robert D. Stevens,Jason R.B. Dyck,Christopher B. Newgard,Gary D. Lopaschuk,Deborah M. Muoio	1551

About Merrie Mosedale

Merrie Mosedale is a scholar working on Pharmacology, Hepatology and Biochemistry, having authored 30 papers that have together received 2.5k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (13 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). The work is most often cited by research in Physiology (1.1k citations), Pharmacology (354 citations) and Clinical Biochemistry (200 citations). Merrie Mosedale has collaborated with scholars based in United States, United Kingdom and Saudi Arabia. Frequent co-authors include Deborah M. Muoio, Timothy R. Koves, James R. Bain, John R. Ussher, Olga Ilkayeva, Robert C. Noland, Christopher B. Newgard, Dorothy H. Slentz, Gary D. Lopaschuk and Robert D. Stevens. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact